Quick Answer
CytoMed Therapeutics Ltd reported Total Assets of $6.21 million for fiscal year 2025.
CytoMed Therapeutics Ltd Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $6.21M | -38.3% |
| 2024 | $10.07M | -18.6% |
| 2023 | $12.37M | +136.6% |
| 2022 | $5.23M | -14.1% |
| 2021 | $6.08M | — |
- CytoMed Therapeutics Ltd showed a decrease of -38.3% in Total Assets compared to the prior fiscal year.
- Over the 2021–2025 period, CytoMed Therapeutics Ltd’s total assets has grown by 2.1% (from $6.08 million to $6.21 million).
- The most recent figure is from CytoMed Therapeutics Ltd’s fiscal year 2025 report (Form 20-F), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: